Aflibercept to Prevent Vision Complications of Diabetic Retinopathy, History of Adverse Pregnancy Outcomes and CT-Identified Coronary Artery Disease, Review of Managing Menopausal Symptoms, and more

Release Date:

Editor’s Summary by Kirsten Bibbins-Domingo, PhD, MD, MAS, Editor in Chief of JAMA, the Journal of the American Medical Association, for the February 7, 2023, issue. Related Content: Audio Highlights

Aflibercept to Prevent Vision Complications of Diabetic Retinopathy, History of Adverse Pregnancy Outcomes and CT-Identified Coronary Artery Disease, Review of Managing Menopausal Symptoms, and more

Title
Aflibercept to Prevent Vision Complications of Diabetic Retinopathy, History of Adverse Pregnancy Outcomes and CT-Identified Coronary Artery Disease, Review of Managing Menopausal Symptoms, and more
Copyright
Release Date

flashback